ALK+ Inflammatory Myofibroblastic Tumor of the Tongue in a Neonate Treated With Crizotinib

The authors present a case of a neonate born with an enlarging tongue mass whose biopsy revealed IMT with ALK positivity. Treatment included tumor debulking and an ALK inhibitor, crizotinib, which resulted in complete remission.